Tirzepatide denied for missing prior authorization by Anthem?

Anthem's specific coverage criteria for tirzepatide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Anthem Denies Tirzepatide for Prior Authorization

A prior-authorization (PA) denial for tirzepatide from Anthem means the medication was dispensed or requested without obtaining advance approval, or that the PA request was submitted but did not satisfy Anthem's coverage criteria as documented. PA is Anthem's gatekeeping mechanism for higher-cost medications; it is not an inherent judgment that the drug is inappropriate for you — it is a process requirement. When the PA is denied, you have full appeal rights.

The most common reasons a PA denial issues: the initial request lacked required clinical documentation, the prescriber did not attest to all required criteria, or the request was submitted after the drug was already dispensed (a retrospective PA). Each scenario has a viable path forward.

## Your Federal Appeal Rights

• ACA §2719 / External Review: After exhausting Anthem's internal appeal process, you may request independent external review from a certified IRO. The window to request external review is typically around four months from the final internal denial date — your denial letter must state the exact deadline.
• ERISA §503 Full-and-Fair Review: ERISA-governed plans must give you access to the specific clinical criteria used to deny the PA and must consider new evidence you submit on appeal.
• Expedited PA and Appeal: If you are currently on tirzepatide or your clinical situation is urgent, request an expedited PA reconsideration and, if denied, an expedited appeal — decisions are typically required within 72 hours of an expedited request.

## Appeal Timeline

1. Obtain the denial letter and Anthem's PA clinical criteria document for tirzepatide immediately. 2. Work with your prescriber to resubmit (or appeal) with complete documentation within 30 days of denial to preserve all timelines. 3. Internal appeal decisions are typically required within 30 days (pre-service) or 60 days (post-service). 4. If internally denied, file for external review before the deadline on the denial letter.

## Documentation to Gather

• Complete prescriber PA attestation: A signed letter or form in which the prescriber affirms each criterion in Anthem's PA policy is met, with specific chart references for each.
• Diagnosis and clinical severity: Office notes, lab results, imaging, or specialist records confirming the diagnosis and its clinical impact.
• Prior treatment history: Documented names, dates, durations, and outcomes or intolerances for every prior therapy Anthem's PA criteria require.
• Relevant comorbidities: Documentation of weight-related or metabolic comorbidities that establish clinical necessity.
• Prescriber contact availability: Anthem may request peer-to-peer review; ensure the prescriber is available and prepared.

## Criteria-Mapping Structure

Obtain Anthem's current PA criteria document for tirzepatide — it will list each required element. Build your appeal as a table: left column lists Anthem's criterion verbatim; right column cites the specific chart document (with date and page) that satisfies it. If any criterion is not yet documented in the chart, coordinate with the prescriber to add a clinical note before filing. Peer-to-peer calls between the prescriber and Anthem's medical director resolve a significant share of PA denials without full appeal — request one if offered.